Sign in: Staff/Students
Today marks World Cancer Day 2021 – a day that unites people, communities and entire countries to raise awareness and take action.
Despite the global pandemic, it’s been a busy year for cancer research in Liverpool as our scientists continue to work on cancer prevention, screening, diagnostics and therapeutics for the benefit of cancer patients.
Here, we round up our cancer research news stories from the past 12 months.
In April, researchers from the Liverpool Head and Neck Centre joined an international research collaboration to establish whether operating on head and neck cancers was safe for both patients and clinical staff in the COVID-19 era. Professor Richard Shaw and colleagues in the COVIDSurg-Cancer Collaborative examined information on 1,137 patients with head and neck cancer undergoing potentially curative surgery in 26 countries. Their study, published in the journal Cancer, found that this surgery is safe for patients even when lengthy and complex.
In September, Liverpool researchers launched a new UK study to assess the impact of COVID-19 on people with cancer. The Clinical Characterisation Protocol (CCP) CANCER-UK project is running over 12 months and examining questions that are important for the care of patients with cancer. The study will also determine COVID-19 infection and mortality rates in people with different types of cancer, as well as those receiving different treatments, by collecting and analysing patient data.
June saw the opening of the Clatterbridge Cancer Centre – Liverpool, a major specialist cancer hospital that brings together cancer experts from the NHS and the University on the same site in the city’s Knowledge Quarter. The hospital delivers a wide range of highly-specialist cancer care and has significantly enhanced the opportunity for collaborative leading-edge cancer research, including early-phase clinical trials of new treatments.
In November, the University and local NHS partners announced a major new programme of immunology cancer research. World-leading experimental cancer researcher Professor Christian Ottensmeier was appointed to lead a team of interdisciplinary researchers as part of a strategic investment to drive forward cutting-edge patient relevant research in the region.
January saw the publication of a study by Professor Carlo Palmieri and colleagues that found new evidence about the positive role of androgens in breast cancer treatment. The findings were reinforced by positive data from a phase 2 trial of enobosarm, an androgen receptor activating agent for the treatment of oestrogen receptor-positive (ER-positive) metastatic breast cancer, which were presented by Professor Palmieri at the 2020 San Antonio Breast Cancer Symposium in December.
For more information about World Cancer Day please visit www.worldcancerday.org
All recent news
14: Dame Louise Ellman and Professor William Hope
Play your part in #TeamLivUni
How we are safely welcoming live audiences back for Liverpool Literary Festival 2021
Our favourite images from Welcome Week 2021
Heseltine Institute report for LCR APPG leads calls for Westminster to deliver “clean, green and inclusive growth”
Liverpool is leading a new global network to bring together animal & human #coronavirus research communities.
Funded by @UKRI partners include @APHAgovuk @roslininstitute @Pirbright_Inst @Cambridge_Uni
#OneHealth #LivUniCovid @ThePandemicInst @livuniHLS https://bit.ly/3AEEqHr
Preventing the next global pandemics depends on the collective capacity of universities. For @Wonkhe this morning I’ve written about Liverpool, Covid-19 and @ThePandemicInst, and what next: https://wonkhe.com/blogs/if-pandemics-are-predictable-could-they-be-preventable/
Researchers from @livuniHLS have contributed to new research showing that llama antibodies have 'significant potential' as a #COVID19 treatment.
Published in @NatureComms today, the study was led by @RosFrankInst.
#LivUniCovid | @molvirol | @LivUni_IVES